Brasso K, Skaarup P, Roosen J U, Iverson P
H:S Rigshospitalet, kirurgisk afdeling D.
Ugeskr Laeger. 1998 Jul 27;160(31):4510-6.
Since it was first introduced, measurement of prostate specific antigen has gained increasing interest, and prostate specific antigen is regarded as being the best tumour marker available. The antigen lacks cancer specificity, limiting the usefulness in early diagnosis, The use of prostate specific antigen in early diagnosis, staging, and in monitoring patients with prostate cancer is reviewed.
自首次引入以来，前列腺特异性抗原的检测越来越受到关注，并且前列腺特异性抗原被认为是现有的最佳肿瘤标志物。该抗原缺乏癌症特异性，限制了其在早期诊断中的实用性。本文综述了前列腺特异性抗原在前列腺癌早期诊断、分期及患者监测中的应用。
